LICENSE AGREEMENTLicense Agreement • January 4th, 2016 • Audentes Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 4th, 2016 Company Industry JurisdictionThis License Agreement (“Agreement”) is made as of September 26, 2014 (the “Effective Date”) by and between the Fondazione Salvatore Maugeri, an organization established under the laws of Italy (“FSM”), and Cardiogen Sciences, Inc., a Delaware corporation (“Cardiogen”). Each of FSM and Cardiogen are referred to herein as “Party” and together as the “Parties.”
LICENSE AGREEMENTLicense Agreement • December 18th, 2015 • Audentes Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 18th, 2015 Company Industry JurisdictionThis License Agreement (“Agreement”) is made as of September 26, 2014 (the “Effective Date”) by and between the Fondazione Salvatore Maugeri, an organization established under the laws of Italy (“FSM”), and Cardiogen Sciences, Inc., a Delaware corporation (“Cardiogen”). Each of FSM and Cardiogen are referred to herein as “Party” and together as the “Parties.”